XTRA:SRT3Life Sciences
Sartorius (XTRA:SRT3) Margin Upswing Reinforces Bullish Narratives Despite Premium Valuation
Sartorius (XTRA:SRT3) delivered robust earnings growth this period, with net profit margins rising to 3% from 2.3% a year ago. EPS surged 32.8% over the past year, a sharp rebound after averaging a 16.5% annual decline over the last five years. Looking ahead, analysts forecast annual EPS growth of 22.1% and revenue growth of 9.4%, both outpacing broader German market averages, while investors remain focused on the company’s consistently high quality earnings.
See our full analysis for...